CorMatrix Cardiovascular Inc is a world leader in cardiovascular regeneration products, specializing in the development of innovative solutions for valvular heart disease, structural heart disorders, and myocardial infarction. Their flagship product, CorPatch, is an extracellular matrix scaffold designed to support and repair weakened cardiac tissue during surgery, allowing the patient's own cells to naturally rebuild and strengthen the heart. Additionally, CorMatrix is pioneering the development of the CorTricuspid ECM Valve, a groundbreaking solution for the surgical management of tricuspid valve disease and dysfunction in both adult and pediatric patients.
With a team of experienced leaders, including CEO John P. Engels and Co-Founder Dr. Robert Matheny, CorMatrix combines deep knowledge of biologic and ECM devices with a strong focus on regulatory compliance. Their commitment to innovation and patient care has earned them FDA approval for landmark pivotal trials and positioned them as a trusted name in the field of cardiovascular regeneration. As they continue to expand their product pipeline and make advancements in the treatment of cardiovascular diseases, CorMatrix remains dedicated to improving the quality of life for patients worldwide.
Generated from the website